Core Biopsy Needle Market Growth Report 2021 to 2031
The Core Biopsy Needle Market is expected to register a CAGR of 8.30% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by type (disposable and reusable). The report is segmented by material (latex and latex free) and based on application (endo cavity and external cavity). The report further provides analysis based on end user (hospitals, ambulatory surgical centers, clinics, and diagnostic centers). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Core Biopsy Needle Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Core Biopsy Needle Market Segmentation
Type- Disposable and Reusable
- Latex and Latex free
- Endo Cavity and External Cavity
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Diagnostic Centers
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Diagnostic Centers
Strategic Insights
Core Biopsy Needle Market Growth Drivers- Rising Incidence of Cancer: The core biopsy needle market experiences a high and significant growth rate due to the increasing incidence of various cancers globally, especially breast, lung, and prostate cancers. Since cancer is still one of the primary causes of death, there is an increased need for precise and early diagnostic tools such as core needle biopsies, which may enable better treatment decisions at an appropriate time for patients.
- Awareness and Screening Efforts: Higher public awareness in respect of the cancer symptoms and the need for early diagnosis has led to more screening efforts. This increased awareness prods more patients to go for biopsies when required. This thus opens up the demand for core biopsy needles as the healthcare providers strive to meet the increased demand for diagnostic procedures.
- Technological Advancements: Developed innovations in core biopsy needles include fully automated and image-guided systems. These innovations reduce trauma; minimize or eliminate bleeding risks; and improve recovery times. Robotic assistance also increases the precision of diagnosis, thus encouraging healthcare providers to employ these innovations.
- Minimally Invasive Techniques: There is an ever-increasing trend toward minimally invasive biopsy techniques as patients and providers care more for quicker recovery periods and lower complication rates. Core needle biopsies are in step with this trend with effective tissue sampling and less trauma than the traditional surgery technique.
- More Use of Imaging Guidance: The use of advanced imaging technologies such as ultrasound and MRI in conjunction with biopsy is becoming the norm. With this trend, the accuracy of needle placement in biopsies increases, and thus the improvement in outcomes and reduced chance of a repeat procedure due to inadequate sampling.
- Sustainability Initiatives: Manufacturers are now incorporating sustainability, with the development of green biopsy needles and innovative packaging solutions. This is a more widespread approach across the healthcare industry as such companies promote sustainability without diminishing their quality care for patients
- Expansion in Emerging Markets: The manufacturers of manufacturing have large potential in emerging markets because of rapid development of the health care infrastructure. Huge potential exists for the company to provide affordable and effective core biopsy solutions to these regions; hence it will result in adding new customers and promoting growth into previously untapped markets.
- Product innovation: There exists constant impetus for design innovation in core biopsy needles toward greater ease of use and effectiveness. New opportunities are there for manufacturers for new features-these could be enhanced or improved visibility under imaging guidance or even automation capabilities to address new clinical needs.
- Collaboration with health care providers:Strategic partnerships would help the manufacturers with the insight into more specific needs and preferences in the various markets. They would eventually lead to joint development projects and customized solutions that meet unique challenges of the healthcare providers.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Core Biopsy Needle Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Core Biopsy Needle Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Narang Medical; Chemyx; DIXION; Becton, Dickinson and Company; Smiths Medical; Cardinal Health; Lead Fluid; B Braun; Baxter; and KD Scientific, Inc. are some of the major players operating in the market.
The ICU segment accounts for the highest revenue in application segment of the core biopsy needle market in 2023.
Asia Pacific region dominated the core biopsy needle market in 2023
North America region dominated the core biopsy needle market in 2023
The Core Biopsy Needle Market is estimated to witness a CAGR of 8.30% from 2023 to 2031
Increasing Incidence of Cancer is a major factors driving the core biopsy needle market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Core Biopsy Needle Market - By Type
1.3.2 Core Biopsy Needle Market - By Application
1.3.3 Core Biopsy Needle Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CORE BIOPSY NEEDLE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CORE BIOPSY NEEDLE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CORE BIOPSY NEEDLE MARKET - GLOBAL MARKET ANALYSIS
6.1. CORE BIOPSY NEEDLE - GLOBAL MARKET OVERVIEW
6.2. CORE BIOPSY NEEDLE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CORE BIOPSY NEEDLE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEMI-AUTOMATIC
7.3.1. Overview
7.3.2. Semi-automatic Market Forecast and Analysis
7.4. AUTOMATIC
7.4.1. Overview
7.4.2. Automatic Market Forecast and Analysis
7.5. AND MANUAL
7.5.1. Overview
7.5.2. and Manual Market Forecast and Analysis
8. CORE BIOPSY NEEDLE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. KIDNEY
8.3.1. Overview
8.3.2. Kidney Market Forecast and Analysis
8.4. LIVER
8.4.1. Overview
8.4.2. Liver Market Forecast and Analysis
8.5. BREAST
8.5.1. Overview
8.5.2. Breast Market Forecast and Analysis
8.6. PROSTATE
8.6.1. Overview
8.6.2. Prostate Market Forecast and Analysis
8.7. LUNGS AND OTHERS.
8.7.1. Overview
8.7.2. Lungs and Others. Market Forecast and Analysis
9. CORE BIOPSY NEEDLE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Core Biopsy Needle Market Overview
9.1.2 North America Core Biopsy Needle Market Forecasts and Analysis
9.1.3 North America Core Biopsy Needle Market Forecasts and Analysis - By Type
9.1.4 North America Core Biopsy Needle Market Forecasts and Analysis - By Application
9.1.5 North America Core Biopsy Needle Market Forecasts and Analysis - By Countries
9.1.5.1 United States Core Biopsy Needle Market
9.1.5.1.1 United States Core Biopsy Needle Market by Type
9.1.5.1.2 United States Core Biopsy Needle Market by Application
9.1.5.2 Canada Core Biopsy Needle Market
9.1.5.2.1 Canada Core Biopsy Needle Market by Type
9.1.5.2.2 Canada Core Biopsy Needle Market by Application
9.1.5.3 Mexico Core Biopsy Needle Market
9.1.5.3.1 Mexico Core Biopsy Needle Market by Type
9.1.5.3.2 Mexico Core Biopsy Needle Market by Application
9.2. EUROPE
9.2.1 Europe Core Biopsy Needle Market Overview
9.2.2 Europe Core Biopsy Needle Market Forecasts and Analysis
9.2.3 Europe Core Biopsy Needle Market Forecasts and Analysis - By Type
9.2.4 Europe Core Biopsy Needle Market Forecasts and Analysis - By Application
9.2.5 Europe Core Biopsy Needle Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Core Biopsy Needle Market
9.2.5.1.1 Germany Core Biopsy Needle Market by Type
9.2.5.1.2 Germany Core Biopsy Needle Market by Application
9.2.5.2 France Core Biopsy Needle Market
9.2.5.2.1 France Core Biopsy Needle Market by Type
9.2.5.2.2 France Core Biopsy Needle Market by Application
9.2.5.3 Italy Core Biopsy Needle Market
9.2.5.3.1 Italy Core Biopsy Needle Market by Type
9.2.5.3.2 Italy Core Biopsy Needle Market by Application
9.2.5.4 United Kingdom Core Biopsy Needle Market
9.2.5.4.1 United Kingdom Core Biopsy Needle Market by Type
9.2.5.4.2 United Kingdom Core Biopsy Needle Market by Application
9.2.5.5 Russia Core Biopsy Needle Market
9.2.5.5.1 Russia Core Biopsy Needle Market by Type
9.2.5.5.2 Russia Core Biopsy Needle Market by Application
9.2.5.6 Rest of Europe Core Biopsy Needle Market
9.2.5.6.1 Rest of Europe Core Biopsy Needle Market by Type
9.2.5.6.2 Rest of Europe Core Biopsy Needle Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Core Biopsy Needle Market Overview
9.3.2 Asia-Pacific Core Biopsy Needle Market Forecasts and Analysis
9.3.3 Asia-Pacific Core Biopsy Needle Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Core Biopsy Needle Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Core Biopsy Needle Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Core Biopsy Needle Market
9.3.5.1.1 Australia Core Biopsy Needle Market by Type
9.3.5.1.2 Australia Core Biopsy Needle Market by Application
9.3.5.2 China Core Biopsy Needle Market
9.3.5.2.1 China Core Biopsy Needle Market by Type
9.3.5.2.2 China Core Biopsy Needle Market by Application
9.3.5.3 India Core Biopsy Needle Market
9.3.5.3.1 India Core Biopsy Needle Market by Type
9.3.5.3.2 India Core Biopsy Needle Market by Application
9.3.5.4 Japan Core Biopsy Needle Market
9.3.5.4.1 Japan Core Biopsy Needle Market by Type
9.3.5.4.2 Japan Core Biopsy Needle Market by Application
9.3.5.5 South Korea Core Biopsy Needle Market
9.3.5.5.1 South Korea Core Biopsy Needle Market by Type
9.3.5.5.2 South Korea Core Biopsy Needle Market by Application
9.3.5.6 Rest of Asia-Pacific Core Biopsy Needle Market
9.3.5.6.1 Rest of Asia-Pacific Core Biopsy Needle Market by Type
9.3.5.6.2 Rest of Asia-Pacific Core Biopsy Needle Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Core Biopsy Needle Market Overview
9.4.2 Middle East and Africa Core Biopsy Needle Market Forecasts and Analysis
9.4.3 Middle East and Africa Core Biopsy Needle Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Core Biopsy Needle Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Core Biopsy Needle Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Core Biopsy Needle Market
9.4.5.1.1 South Africa Core Biopsy Needle Market by Type
9.4.5.1.2 South Africa Core Biopsy Needle Market by Application
9.4.5.2 Saudi Arabia Core Biopsy Needle Market
9.4.5.2.1 Saudi Arabia Core Biopsy Needle Market by Type
9.4.5.2.2 Saudi Arabia Core Biopsy Needle Market by Application
9.4.5.3 U.A.E Core Biopsy Needle Market
9.4.5.3.1 U.A.E Core Biopsy Needle Market by Type
9.4.5.3.2 U.A.E Core Biopsy Needle Market by Application
9.4.5.4 Rest of Middle East and Africa Core Biopsy Needle Market
9.4.5.4.1 Rest of Middle East and Africa Core Biopsy Needle Market by Type
9.4.5.4.2 Rest of Middle East and Africa Core Biopsy Needle Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Core Biopsy Needle Market Overview
9.5.2 South and Central America Core Biopsy Needle Market Forecasts and Analysis
9.5.3 South and Central America Core Biopsy Needle Market Forecasts and Analysis - By Type
9.5.4 South and Central America Core Biopsy Needle Market Forecasts and Analysis - By Application
9.5.5 South and Central America Core Biopsy Needle Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Core Biopsy Needle Market
9.5.5.1.1 Brazil Core Biopsy Needle Market by Type
9.5.5.1.2 Brazil Core Biopsy Needle Market by Application
9.5.5.2 Argentina Core Biopsy Needle Market
9.5.5.2.1 Argentina Core Biopsy Needle Market by Type
9.5.5.2.2 Argentina Core Biopsy Needle Market by Application
9.5.5.3 Rest of South and Central America Core Biopsy Needle Market
9.5.5.3.1 Rest of South and Central America Core Biopsy Needle Market by Type
9.5.5.3.2 Rest of South and Central America Core Biopsy Needle Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CORE BIOPSY NEEDLE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CORE BIOPSY NEEDLE MARKET, KEY COMPANY PROFILES
12.1. HILL- ROM CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. RANFAC CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SOMATE MEDICAL TECHNOLOGIES GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TSK LABORATORY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. REMINGTON MEDICAL INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. RI.MOS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. COLOPLAST
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERIT MEDICAL SYSTEMS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BD BIOSCIENCES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. KIMAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Hill-Rom Corporation
2. Ranfac Corporation
3. SOMATEX Medical Technologies GmbH
4. TSK Laboratory
5. Remington Medical Inc
6. RI. MOS
7. Coloplast
8. Merit Medical Systems, Inc
9. BD Biosciences
10. Kimal
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.